Current Price
WuXi PharmaTech (Cayman) Inc. is a leading global contract research and manufacturing organization that provides comprehensive services for the pharmaceutical, biotechnology, and medical device industries. The company sp...|
e.g. Promoter holding
Loading chart...
Analyst consensus EPS and Revenue forecasts.
Earnings estimates are not available for this company.
| S.No. | Name | Symbol | Market Cap | P/E | P/B | Profit Margin | Op. Margin | ROE | Rev. Growth |
|---|---|---|---|---|---|---|---|---|---|
| 1. | AACCOM INC | ACMM | — | — | — | — | — | — | — |
| 2. | AActions Se... | ACTS | — | — | — | — | — | — | — |
| 3. | AAegon Fund... | AEFC | — | — | — | — | — | — | — |
| 4. | AFederal Ag... | AGM-P-D | — | — | — | — | — | — | — |
| 5. | AArmada Hof... | AHH-P-A | — | — | — | — | — | — | — |
Consolidated Figures in Millions / View Standalone.
| Quarter (M) | Dec 13 | Mar 14 | Jun 14 | Sep 14 | Dec 14 | Mar 15 | Jun 15 | Sep 15 |
|---|---|---|---|---|---|---|---|---|
Revenue | 157.17 | 146.72 | 163.35 | 173.56 | 190.65 | 180.04 | 194.14 | 213.64 |
COGS | 97.5 | 93.09 | 101.82 | 107.37 | 120.26 | 117.23 | 127.44 | 137.75 |
Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit % | - | - | - | - | - | - | - | - |
| 33.55 | 34.59 | 38.37 | 44.16 | 52.11 | 52.19 | 57.33 | 57.09 | |
EBIT | 29.36 | 23.41 | 28 | 27.75 | 24.56 | 16.99 | 17.05 | 25.82 |
OPM % | 18.68% | 15.96% | 17.14% | 15.99% | 12.88% | 9.44% | 8.78% | 12.09% |
Non-Operating Income | 11.37 | -1.72 | 8.01 | 11.51 | 15.09 | 5.04 | 5.82 | -5.3 |
PBT | 40.74 | 21.69 | 36.01 | 39.26 | 39.65 | 22.03 | 22.87 | 20.52 |
Income Tax | 7.88 | 3.87 | 6.67 | 7.26 | 6.65 | 4.25 | 3.42 | 4.45 |
Tax Rate % | 19.35% | 17.84% | 18.53% | 18.49% | 16.78% | 19.27% | 14.96% | 21.7% |
Net Income | 32.86 | 17.82 | 29.34 | 32 | 33 | 17.79 | 18.87 | 15.1 |
NPM % | 20.9% | 12.15% | 17.96% | 18.44% | 17.31% | 9.88% | 9.72% | 7.07% |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 33.78 | 69.94 | 135.21 | 253.49 | 270.02 | 334.06 | 407.18 | 499.91 | 578.08 | 674.28 |
COGS | 13.47 | 31.77 | 63.4 | 126.11 | 137.64 | 174.15 | 216.74 | 275 | 321.78 | 376.18 |
Gross Profit | 20.31 | 38.17 | 71.81 | 127.38 | 132.38 | 159.91 | 190.44 | 224.91 | 256.31 | 298.1 |
Gross Profit % | 60.12% | 54.58% | 53.11% | 50.25% | 49.03% | 47.87% | 46.77% | 44.99% | 44.34% | 44.21% |
| 9.54 | 24.18 | 32.66 | 56.77 | 56.28 | 50.58 | 78.03 | 101.93 | 117.27 | 169.23 | |
EBIT | 8.74 | 10.13 | 30.2 | 39.57 | 52.13 | 80.12 | 83.81 | 89.44 | 105.24 | 103.73 |
OPM % | 25.87% | 14.48% | 22.33% | 15.61% | 19.31% | 23.98% | 20.58% | 17.89% | 18.21% | 15.38% |
Non-Operating Income | -1.54 | -0.88 | 5.21 | 0 | 6.83 | 20.93 | 13.78 | 14.53 | 32.79 | 32.88 |
PBT | 7.2 | 9.25 | 35.4 | 0 | 58.96 | 101.06 | 97.58 | 103.98 | 138.03 | 136.61 |
Income Tax | 1.07 | 0.4 | 1.5 | 0 | 5.53 | 10.24 | 16.61 | 17.39 | 23.46 | 24.45 |
Tax Rate % | 14.92% | 4.3% | 4.23% | - | 9.38% | 10.14% | 17.02% | 16.73% | 17% | 17.9% |
Net Income | 6.13 | 8.85 | 33.9 | 0 | 52.87 | 90.81 | 80.98 | 86.58 | 114.57 | 112.16 |
NPM % | 18.14% | 12.66% | 25.08% | - | 19.58% | 27.18% | 19.89% | 17.32% | 19.82% | 16.63% |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| 4.87 | 9.68 | 213.59 | 56.63 | 80.51 | 115.4 | 71.37 | 54.13 | 88.87 | 211.46 | |
| 0.62 | 2.07 | 5.53 | 15.97 | 23.44 | 40.07 | 130.51 | 175.67 | 305.41 | 224.33 | |
| 22.83 | 42.78 | 73.64 | 152.7 | 181.83 | 205.55 | 245.69 | 264.38 | 279.25 | 351.69 | |
| 4.59 | 12.31 | 24.57 | 20.71 | 24.4 | 32.4 | 60.48 | 66.58 | 76.53 | 80.54 | |
| 7.97 | 18.85 | 26.46 | 90.39 | 97.12 | 104.71 | 156.09 | 181.77 | 198.8 | 313.62 | |
Total Assets | 40.87 | 85.69 | 343.77 | 336.4 | 407.3 | 498.13 | 664.14 | 742.53 | 948.87 | 1,181.63 |
| 4.98 | 4.62 | 9.85 | 10.59 | 11.01 | 11.22 | 11.41 | 11.22 | 11.45 | 11.22 | |
| 12.26 | 43.56 | 241.55 | 220.29 | 269.12 | 381.61 | 494.32 | 567 | 723.3 | 766.63 | |
| 5.04 | 5.76 | 45.09 | 38.17 | 37.98 | 37.72 | 1.65 | 5.7 | 11.12 | 13.99 | |
| 8.39 | 20.93 | 41.51 | 50.54 | 44.02 | 56.54 | 74 | 84.03 | 119.15 | 163.75 | |
| 10.19 | 10.82 | 5.77 | 16.82 | 45.17 | 11.05 | 82.78 | 74.59 | 83.85 | 226.03 | |
Total Liabilities | 40.87 | 85.69 | 343.77 | 336.4 | 407.3 | 498.13 | 664.14 | 742.53 | 948.87 | 1,181.63 |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| 9.06 | 15.33 | 65.23 | 60.66 | 69.77 | 125.65 | 101.06 | 131.06 | 181.51 | 140.38 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 3.58 | 15.54 | 180.49 | 0 | 27.98 | 0 | 29.77 | 0 | 17.93 | 38.14 | |
Net CFNet Cash Flow | 12.63 | 30.87 | 245.72 | 60.66 | 97.76 | 125.65 | 130.84 | 131.06 | 199.44 | 178.52 |
FCFFree Cash Flow | 0.65 | -9 | 25.13 | -2.59 | 14.78 | 76.78 | 37.66 | 64.19 | 128.08 | 42.25 |
Financial ratios and valuation metrics by fiscal year.
| Period | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 27.1% | 22.6% | - | 20.7% | 27.0% | 18.0% | 16.0% | 17.5% | 14.8% | |
| 0.29 | 0.12 | 0.18 | 0.17 | 0.14 | 0.10 | 0.00 | 0.01 | 0.02 | 0.02 | |
| - | - | - | - | - | - | - | - | - | - | |
| - | 1.11 | 0.63 | 0.75 | 0.73 | 0.74 | 0.70 | 0.71 | 0.68 | 0.63 | |
Cash Conversion | 1.48 | 1.73 | 1.92 | - | 1.32 | 1.38 | 1.25 | 1.51 | 1.58 | 1.25 |
Payout Ratio | 27.5% | 76.2% | - | - | - | - | - | - | - | - |
| - | 107.0% | 93.3% | 87.5% | 6.5% | 23.7% | 21.9% | 22.8% | 15.6% | 16.6% | |
| - | - | - | - | - | - | - | - | - | - | |
| - | - | - | - | - | - | - | - | - | - | |
| 4.00 | 5.00 | 3.00 | 3.00 | 4.00 | 6.00 | 4.00 | 5.00 | 4.00 | 4.00 | |
| - | -1.72 | -1.66 | -2.71 | -2.57 | -2.42 | -2.44 | -2.51 | -2.62 | -2.63 | |
| 100.00 | 95.00 | 90.00 | 100.00 | 90.00 | 95.00 | 90.00 | 85.00 | 90.00 | 85.00 | |
| 0.2% | 0.1% | 0.3% | - | 0.2% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
Who owns WuXi PharmaTech Cayman Inc. ADR, from SEC filings
Shares sold short · updated twice a month
| Settlement date | Short shares | Change | Days to cover | Relative size |
|---|---|---|---|---|
| 30 Oct 2026 | 456 | +1202.9% | 3.48 | |
| 15 Oct 2026 | 35 | -87.1% | 1.00 | |
| 30 Sep 2026 | 271 | -13.7% | 1.00 | |
| 15 Sep 2026 | 314 | +188.1% | 1.93 | |
| 31 Aug 2026 | 109 | +28.2% | 1.00 | |
| 14 Aug 2026 | 85 | +54.5% | 1.47 | |
| 31 Jul 2026 | 55 | +111.5% | 1.17 | |
| 15 Jul 2026 | 26 | +85.7% | 1.86 | |
| 30 Jun 2026 | 14 | -58.8% | 1.00 | |
| 15 Jun 2026 | 34 | 1.00 |
FINRA consolidated short interest, reported twice a month for every US listing.
WuXi PharmaTech Cayman Inc. ADR's SEC filings and earnings call transcripts
What recent news says about WuXi PharmaTech Cayman Inc. ADR, scored for sentiment.